Dr Nicole Tsang is currently a Post-doctoral Fellow in the School of Public Health, the University of Hong Kong. Dr Tsang obtained her MPH with distinction and PhD in the University of Hong Kong. Her research work primarily focuses on the public health and epidemiological considerations in the control of epidemic and pandemic respiratory infections, including the vaccine effectiveness, vaccine side effects profiles, vaccine acceptance, impact of school-based vaccination programme, effective disease control and vaccination strategies in community settings, diagnostic test performance, and novel approaches for disease surveillance to inform situational awareness of evolving epidemics.

Dr Tsang is involved in facilitating several postgraduate public health modules. She is an Associate Fellow of the Advanced Higher Education, and a member of the European Respiratory Society Clinical Practice Guidelines Methodology Network, and the European Society of Clinical Microbiology and Infectious Diseases Evidence Review Group. Dr Tsang has received numerous awards including young investigator awards, the Bill & Melinda Gates Foundation Professional Development Award, HKU Foundation Publication Award, Leong Che-Hung Medical and Research Enrichment Scholarship, and YS and Christabel Lung Postgraduate Scholarship.

1. Tsang NNY, So HC, Cowling BJ, Leung GM, Ip DKM. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 Omicron BA.2 in Hong Kong: a prospective cohort study. 2022. The Lancet Infectious Diseases. 2022. https://doi.org/10.1016/S1473-3099(22)00732-0
   [IF 56.3, ranked 1 out of 128 under the category of “Infectious Diseases”] (first author)
2. Tsang NNY, So HC, Ng KY, Cowling BJ, Leung GM, Ip DKM. Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis. The Lancet Infectious Diseases. 2021;21(9):1233-45. https://doi.org/10.1016/S1473-3099(21)00146-8
   [IF 56.3, ranked 1 out of 128 under the category of “Infectious Diseases”] (first author)
3. Tsang NNY, So HC, Ip DKM. Is oropharyngeal sampling a reliable test to detect SARS-CoV-2? Authors' reply. The Lancet Infectious Diseases. 2021;21(10):1348-9. https://doi.org/10.1016/S1473-3099(21)00402-3
   [IF 56.3, ranked 1 out of 128 under the category of “Infectious Diseases”] (first author)
4. Tsang NNY, So HC, Cowling BJ, Leung GM, Ip DKM. Performance of saline and water gargling for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis. 2022. European Respiratory Review 2022 Sep 20;31(165):220014. doi: 10.1183/16000617.0014-2022. https://err.ersjournals.com/content/31/165/220014
   [IF 7.5, ranked 11 out of 99 under the category of “Respiratory System”] (first author)
5. Tsang NY, So HC, Ho HF, Leung GM, Ip DKM. Public perception and performance of different sampling approaches for the diagnosis of COVID‐19. Influenza Other Respi Viruses. 2021; 15:420–422. https://doi.org/10.1111/irv.12834
   [IF 4.4, ranked 50 out of 128 under the category of “Infectious Diseases”, ranked 15 out of 41 under the category of “Virology”] (first author)
6. Tsang NNY, So HC, Ip DKM. Using large scale rapid antigen testing (RAT) to inform participatory ad-hoc community surveillance for emerging communicable diseases epidemics. In: Dr. Laura A, editor. Rapid Antigen Testing. Rijeka: IntechOpen; 2023. p. Ch. 3. ISBN 978-1-83769-568-3. https://doi.org/10.5772/intechopen.1002337 (first author)
7. Tsang T, Wang C, Tsang NNY, Fang V, Perera R, Peiris M, Leung GM, Cowling BJ, Ip DKM. Impact of host genetic polymorphisms on response to inactivated influenza vaccine in children. npj Vaccines. 2023 Feb 20;8(1):21. doi: 10.1038/s41541-023-00621-1. https://doi.org/10.1038/s41541-023-00621-1
   [IF 9.2, ranked 17 out of 177 under the category of “Immunology” and ranked 14 out of 189 under the category of “Medicine, Research & Experimental”]